AnnularBio
Driving the Next Generation of Monoclonal Antibody and Glycan Research
AnnularBio is a biotechnology company that provides contract manufacturing and early-stage development of custom monoclonal antibodies (mAbs). AnnularBio’s goal is to provide industry and academic researchers with high quality mAbs through a combination of development speed and optimization of epitope binding. Our focus is exceptional customer service starting at consultation through project completion to ensure we meet your specific needs. We offer the “ABitope Kit”, or a panel of mAbs that gives researchers the ability to utilize a diverse number of antibodies to assist in R&D, diagnostic and therapeutic applications.
At AnnularBio, we believe this represents a unique opportunity for innovation.
Featured Innovations
01
Antibody Innovations
Explore our cutting-edge monoclonal antibodies designed for both protein and glycan targets, ensuring high specificity and reliability in research applications.
02
Glycan Discovery
Our advanced glycan-focused platforms enable precise antibody discovery, facilitating groundbreaking research in complex carbohydrate antigens.
03
Research Excellence
We prioritize research excellence by providing high-quality tools and resources that empower scientists in their quest for innovative solutions in biomedical research.
04
Precision Medicine
Our proprietary ABitope Kit supports reproducible antibody generation, enhancing the accuracy and efficiency of protein research in precision medicine.
05
Quality Assurance
We adhere to stringent quality control measures to ensure that our monoclonal antibodies meet the highest standards for research and clinical applications.
06
Innovative Solutions
Discover innovative solutions that bridge the gap between basic research and clinical applications, driving advancements in biomedical science.
Mission Statement
Accelerating discovery research with high quality, monoclonal antibodies (mAbs) tailored to meet the needs of the Client.
